Exhibit 10.1
LICENSE AGREEMENT
This License Agreement (the
“Agreement”), effective as of October 23, 2006 (the
“Effective Date”), is entered into by and between
Vical, Inc., a Delaware corporation having offices at 863A Mitten
Road, Burlingame, California 94010 (“Valentis”) and
Vical Incorporated, a Delaware corporation having offices at 10309
Pacific Center Court (“Vical”). All references to
Valentis and Vical in this Agreement shall include their Affiliates
(as defined below).
BACKGROUND
A.
Valentis is the owner or exclusive licensee of certain Patent
Rights and Know-How (as such terms are defined below), and Vical
wishes to acquire a license under the Patent Rights and Know-How;
and
B.
Valentis is willing to grant Vical such a license, on the terms and
conditions set forth below.
NOW, THEREFORE, in consideration of
the promises and the mutual covenants hereinafter recited, the
parties agree as follows:
ARTICLE 1.
DEFINITIONS
In this Agreement, the following
terms shall have the meanings set forth in this Article.
1.1
“ Affiliate
” means any
company, corporation, division or other entity which is directly or
indirectly controlling, controlled by or under common control with
a party hereto. For the purpose of this Agreement, with
respect to any company, corporation, division or other entity,
“control” shall mean the direct or indirect ownership
of at least fifty percent (50%) of the outstanding shares or other
voting rights of the subject company, corporation or other entity
to elect directors.
1.2
“ Confidential
Information ” means (a) any
proprietary or confidential information or material in tangible
form disclosed hereunder that is marked as
“Confidential” at the time it is delivered to the
receiving party, or (b) proprietary or confidential information
disclosed orally hereunder which is identified as confidential or
proprietary when disclosed and such disclosure of confidential
information is confirmed in writing within thirty (30) days by the
disclosing party.
1.3
“ Know-How
” means
unpatented and/or unpatentable technical information, including
ideas, concepts, inventions, discoveries, data, designs, formulas,
specifications, procedures for experiments and tests and other
protocols, results of experimentation and testing, fermentation and
purification techniques, and assay protocols owned by Valentis as
of the Effective Date and Vical after the Effective Date which may
be necessary for the practice of the Valentis Patent Rights solely
as contemplated hereunder. Know-How shall not include the
Valentis Patent Rights. All Know-How shall be Confidential
Information of Valentis.
1.4
“ Vical Products
” means any
product or material resulting from Vical’s use of the
Licensed Technology.
1.5
“ Licensed
Technology ” means the Patent
Rights and the Know-How.
1.6
“ Patent Rights
” means the
patent applications and patents expressly listed in Exhibit A
(“Patents”).
1.7
“ Third Party
” means any
person or entity other than Vical or Valentis.
ARTICLE 2.
LICENSE
2.1
Grant to Vical . Subject to the terms
and conditions of this Agreement, Valentis hereby grants to Vical
for the sum of one hundred eighty five thousand dollars
($185,000.00) payable in good US funds upon the Effective Date, a
non-exclusive, worldwide, royalty-free, fully paid up license under
the Licensed Technology, without the right to grant sublicenses
except to either (i) a contract manufacturing organization (CMO)
for the direct manufacture of Vical Products or (ii) in connection
with a written bona-fide research, development and collaboration
agreement with a Third Party, to:
(a)
make, have made, use (by a contract manufacturing organization
solely for the direct manufacturing of Vical Products), export and
import Vical Products;
2.2
No Implied Rights
. Only the
licenses granted pursuant to the express terms of this Agreement
shall be of any legal force or effect. No other license
rights shall be granted or created by implication, estoppel or
otherwise. For the avoidance of doubt, by example only and
without expanding or narrowing the license grants of Sections 2.1,
the grants of rights made pursuant to Sections 2.1 do not include,
and expressly exclude, any right or license (a) to engage in any
activities on behalf of or in collaboration with any Third Party
(other than, in the case of Vical, as applicable), or (b) to
release or waive any claim of infringement under any patent or
patent application owned or controlled by Valentis or its
Affiliates, including, without limitation, the Patent
Rights.
2.3
Ownership; Enforcement; No
Challenge .
(a)
Valentis owns the Licensed Technology, including all embodiments of
the Patent Rights or the Know-How, and may freely use and
commercialize such Licensed Technology itself or with Third
Parties. Valentis retains the right, at its sole discretion,
to enforce, maintain and otherwise protect the Licensed
Technology. Vical shall give Valentis notice of any
infringement by a Third Party of any patent or patent application
owned or controlled by Valentis or misappropriation of the Know-How
which comes to Vical’s knowledge during the term of this
Agreement. Vical will cooperate on a commercially reasonable
basis with Valentis with respect to any actions Valentis may choose
to take pursuant to this Section 2.4, and Valentis will reimburse
Vical for its reasonable costs in this regard.
2
(b)
Except as required under applicable law, Vical shall not
participate, directly or indirectly, in any opposition or challenge
to the validity or enforceability of any Patent in any forum and
Vical shall not assist any Third Party in any such
participation. Any breach by Vical of this Section 2.5(b)
shall constitute a material breach of this Agreement and any
licenses or rights granted hereunder may, at Valentis’
option, be terminable.
2.4
Reports, Records and Audits
.
(a)
Vical shall maintain records fully and properly reflecting those
activities to be reported to Valentis pursuant to Section 2.6(a)
(the “Records”) in sufficient detail and in good
scientific manner appropriate for patent, regulatory and
manufacturing purposes for at least three (3) years after the date
of delivery of the report containing such information. Upon
the written request of Valentis and not more than once in each
calendar year, Vical shall permit an independent third party,
selected by Valentis and reasonably acceptable to Vical, at
Valentis’ expense, to have access during normal business
hours to such of the Records of Vical as may be reasonably
necessary to verify compliance with the terms of this Agreement, as
well as the accuracy of the reports hereunder. Vical shall
certify any statements by Vical personnel as to their accuracy and
correctness.
ARTICLE 3.
IMPROVEMENTS
Valentis shall be free to research,
develop and patent any improvements to the Licensed Technology and,
except as expressly set forth herein, no rights shall be or are to
be construed as granted under this Agreement to Vical to any
patents or patent applications arising from such
activities.
ARTICLE 4.
REPORTS AND RECORDS
4.1
Reports . Vical shall make a
written report to Valentis within thirty (30) days after each
anniversary of the Effective Date describing Vical’
activities under the rights granted to Vical pursuant to Section
2.1. Each such report shall also contain a written
certification that Vical is in material compliance with all
relevant terms and conditions of this Agreement. Valentis
shall treat all such reports as Confidential Information of
Vical.
ARTICLE 5.
CONFIDENTIALITY
5.1
Confidential Information
. Except as
expressly provided herein, the parties agree that, for the term of
this Agreement and for five (5) years thereafter, the receiving
party shall keep confidential and shall not publish or otherwise
disclose, and shall not use for any purpose except for the purposes
contemplated by this Agreement, any Confidential
Information
3
furnished to such
receiving party by a disclosing party hereto, except to the extent
that it can be established by the receiving party by written proof
that such Confidential Information:
(a)
was already known to the receiving party, other than under an
obligation of confidentiality to the disclosing party, at the time
of disclosure;
(b)
was generally available to the public or otherwise part of the
public domain at the time of its disclosure to the receiving
party;
(c)
became generally available to the public or otherwise part of the
public domain after its disclosure other than through any act or
omission of the receiving party in breach of this Agreement;
or
(d)
was subsequently disclosed to the receiving party by a person or
entity with no obligation to the disclosing party with respect to
such information.
5.2
Permitted Use and Disclosures
. Each
party hereto may use or disclose information disclosed to it by the
other party to the extent such use or disclosure is reasonably
necessary for the purposes contemplated by this Agreement, and in
such case pursuant to a confidentiality agreement no less
restrictive than the terms set forth in this Article 6, or in
complying with applicable law or government regulations;
provided, however , that if a party is required to make any
such disclosure of the other party’s Confidential
Information, other than pursuant to such a confidentiality
agreement, it will give reasonable advance notice to such other
party of such disclosure.
5.3
Confidential Terms
. Except as
expressly provided herein, each party agrees that the terms of this
Agreement and the transaction and relationship with Valentis
constitute Confidential Information and are not to be disclosed to
any Third Party without the consent of the other party;
provided that disclosures may be made as required by
securities or other applicable laws, or to a party’s
accountants, attorneys and other professional advisors provided,
however, that the party required to make any such disclosure
will give reasonable advance notice to such other party of such
disclosure.
5.4
Existence of Agreement
. The
parties hereby agree that the consummation of this Agreement, but
not any of the terms hereof, except as otherwise permitted pursuant
to Section 5.3, shall be deemed to be in the public domain and may
be announced or otherwise referred to by a party as deemed
appropriate.
ARTICLE 6.
REPRESENTATIONS AND WARRANTIES
6.1
Representations and
Warranties .
(a)
Valentis represents and warrants that: (i) it is the sole and
exclusive owner or exclusive licensee of all right, title and
interest in the Licensed Technology; (ii) it has the legal right,
authority and power to enter into this Agreement, and to grant the
licenses granted herein; (iii) this Agreement shall constitute a
valid and binding obligation of
4
Valentis
enforceable in accordance with its terms; and (iv) the performance
of its obligations under this Agreement by Valentis shall not
result in a breach of any agreement, contract or other arrangement
to which it is a party.
(b)
Vical represents and warrants that: (i) it has the legal right,
authority and power to enter into this Agreement; (ii) this
Agreement shall constitute a valid and binding obligation of Vical
enforceable in accordance with its terms; and (iii) the performance
of its obligations under this Agreement by Vical shall not result
in a breach of any agreement, contract or other arrangement to
which it is a party.
6.2
Disclaimer . Nothing in this
Agreement is or shall be construed as:
(a)
A warranty or representation by Valentis as to the validity or
scope of any claim or patent within the Patent Rights;
(b)
A warranty or representation by Valentis that anything made, used,
sold, or otherwise disposed of under any license granted in this
Agreement is or will be free from infringement of any patent rights
or other intellectual property right of any Third
Party;
(c)
An obligation to b
|